An Act authorizing a pilot for the use of psychedelics in licensed treatment facilities
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill proposes a pilot program to allow the use of psychedelics, such as psilocybin, in licensed treatment facilities within Massachusetts. The program aims to explore the potential therapeutic benefits of these substances for individuals struggling with mental health and substance use disorders. It would involve carefully controlled settings and qualified professionals to oversee the administration of psychedelics. The goal is to gather data on the safety and effectiveness of this approach.
Key provisions
- Authorizes a pilot program for psychedelic-assisted therapy.
- Specifies that the program must be conducted in licensed treatment facilities.
- Requires the program to adhere to strict safety protocols and guidelines.
- Mandates data collection and reporting on participant outcomes.
- Establishes a review process to evaluate the program's effectiveness.
- Defines the types of psychedelics that may be used under the program.
- Outlines the qualifications for therapists administering psychedelics.
- Requires the Department of Public Health to oversee the program.
Who is affected
- Individuals with mental health disorders
- Individuals with substance use disorders
- Licensed treatment facilities
- Mental Health professionals
- The Department of Public Health
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
James J. O'Day
Cosponsors
James J. O'Day
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours